α-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 146-153

  Ozeri, Eyal ^a   Mizrahi, Mark ^a   Shahaf, Galit ^a   Lewis, Eli C ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; FLUORESCEIN ISOTHIOCYANATE; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN TRANSPLANTATION; TATTOOING;

ALPHA 1-ANTITRYPSIN; ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; GENE KNOCK-IN TECHNIQUES; IMMUNE TOLERANCE; INTERLEUKIN-10; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, CCR7; T-LYMPHOCYTES, REGULATORY;

EID: 84862860546     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101340     Document Type: Article

References (57)

1. Chen, G. Y., and G. Nunez. 2010. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10: 826-837.
2. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161. (Pubitemid 37336516)
3. Allan, R. S., J. Waithman, S. Bedoui, C. M. Jones, J. A. Villadangos, Y. Zhan, A. M. Lew, K. Shortman, W. R. Heath, and F. R. Carbone. 2006. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25: 153-162. (Pubitemid 44066832)
4. Ma, D. Y., and E. A. Clark. 2009. The role of CD40 and CD154/CD40L in dendritic cells. Semin. Immunol. 21: 265-272.
5. Salazar-Fontana, L. I., E. Sanz, I. Mérida, A. Zea, A. Sanchez-Atrio, L. Villa, C. Martínez-A, A. de la Hera, and M. Alvarez-Mon. 2001. Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis. Clin. Immunol. 99: 253-265.
6. Förster, R., A. C. Davalos-Misslitz, and A. Rot. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8: 362-371. (Pubitemid 351595218)
7. Wallis, R. S., P. Kyambadde, J. L. Johnson, L. Horter, R. Kittle, M. Pohle, C. Ducar, M. Millard, H. Mayanja-Kizza, C. Whalen, and A. Okwera. 2004. A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. AIDS 18: 257-264. (Pubitemid 38253448)
8. Xin, H. M., Y. Z. Peng, Z. Q. Yuan, and H. Guo. 2009. In vitro maturation and migration of immature dendritic cells after chemokine receptor 7 transfection. Can. J. Microbiol. 55: 859-866.
9. Ensminger, S. M., S. N. Helm, L. Ohl, B. M. Spriewald, S. Abele, M. Wollin, K. J. Wood, M. Weyand, and R. Förster. 2008. Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3. Transplantation 86: 590-600.
10. Collin, M., V. Bigley, M. Haniffa, and S. Hambleton. 2011. Human dendritic cell deficiency: the missing ID? Nat. Rev. Immunol. 11: 575-583.
11. Hu, J., and Y. Wan. 2011. Tolerogenic dendritic cells and their potential applications. Immunology 132: 307-314.
12. Manicassamy, S., B. Reizis, R. Ravindran, H. Nakaya, R. M. Salazar-Gonzalez, Y. C. Wang, and B. Pulendran. 2010. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329: 849-853.
13. LeGuern, C., Y. Akiyama, S. Germana, K. Tanaka, L. Fernandez, Y. Iwamoto, S. Houser, and G. Benichou. 2010. Intracellular MHC class II controls regulatory tolerance to allogeneic transplants. J. Immunol. 184: 2394-2400.
14. Morelli, A. E., and A. W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7: 610-621. (Pubitemid 47123548)
15. Lutz, M. B., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23: 445-449. (Pubitemid 35015188)
16. Cools, N., P. Ponsaerts, V. F. Van Tendeloo, and Z. N. Berneman. 2007. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J. Leukoc. Biol. 82: 1365-1374. (Pubitemid 350276946)
17. Fu, B. M., X. S. He, S. Yu, A. B. Hu, J. Zhang, Y. Ma, N. L. Tam, and J. F. Huang. 2010. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4+CD25+ T regulatory cells that promotes skin allograft survival in mice. Cell. Immunol. 261: 69-76.
18. Braun, D., L. Galibert, T. Nakajima, H. Saito, V. V. Quang, M. Rubio, and M. Sarfati. 2006. Semimature stage: a checkpoint in a dendritic cell maturation program that allows for functional reversion after signal-regulatory protein-alpha ligation and maturation signals. J. Immunol. 177: 8550-8559. (Pubitemid 44893817)
19. Zou, T., A. J. Caton, G. A. Koretzky, and T. Kambayashi. 2010. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions. J. Immunol. 185: 2790-2799.
20. Chen, Q., Y. C. Kim, A. Laurence, G. A. Punkosdy, and E. M. Shevach. 2011. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo. J. Immunol. 186: 6329-6337.
21. Salcido-Ochoa, F., J. Tsang, P. Tam, K. Falk, and O. Rotzschke. 2010. Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? Transplant. Rev. 24: 52-66.
22. Yamaguchi, T., J. B. Wing, and S. Sakaguchi. 2011. Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions. Semin. Immunol. 23: 424-430.
23. Stoop, J. N., R. A. Harry, A. von Delwig, J. D. Isaacs, J. H. Robinson, and C. M. Hilkens. 2010. Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses. Arthritis Rheum. 62: 3656-3665.
24. Baeke, F., T. Takiishi, H. Korf, C. Gysemans, and C. Mathieu. 2010. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10: 482-496.
25. Segerer, S. E., N. Müller, J. van den Brandt, M. Kapp, J. Dietl, H. M. Reichardt, L. Rieger, and U. Kämmerer. 2009. Impact of female sex hormones on the maturation and function of human dendritic cells. Am. J. Reprod. Immunol. 62: 165-173.
26. Yang, X. J., S. Meng, C. F. Zhu, H. Jiang, and W. X. Wu. 2011. Semi-mature MyD88-silenced bone marrow dendritic cells prolong the allograft survival in a rat model of intestinal transplantation. Chin. Med. J. 124: 268-272.
27. Haase, C., T. N. Jørgensen, and B. K. Michelsen. 2002. Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo. Immunology 107: 489-499. (Pubitemid 36693654)
28. Lewis, E. C., M. Mizrahi, M. Toledano, N. Defelice, J. L. Wright, A. Churg, L. Shapiro, and C. A. Dinarello. 2008. alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc. Natl. Acad. Sci. USA 105: 16236-16241.
29. Koulmanda, M., M. Bhasin, L. Hoffman, Z. Fan, A. Qipo, H. Shi, S. Bonner-Weir, P. Putheti, N. Degauque, T. A. Libermann, et al. 2008. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc. Natl. Acad. Sci. USA 105: 16242-16247.
30. Shahaf, G., H. Moser, E. Ozeri, M. Mizrahi, A. Abecassis, and E. C. Lewis. 2011. α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection. Mol. Med. 17: 1000-1011.
31. Tawara, I., Y. Sun, E. C. Lewis, T. Toubai, R. Evers, E. Nieves, T. Azam, C. A. Dinarello, and P. Reddy. 2012. Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc. Natl. Acad. Sci. USA 109: 564-569.
32. Subramanian, S., G. Shahaf, E. Ozeri, L. M. Miller, A. A. Vandenbark, E. C. Lewis, and H. Offner. 2011. Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice. Metab. Brain Dis. 26: 107-113.
33. Janciauskiene, S. M., I. M. Nita, and T. Stevens. 2007. Alpha1-antitrypsin, old dog, new tricks: alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J. Biol. Chem. 282: 8573-8582. (Pubitemid 47093518)
34. Zhong, X., W. Gao, N. Degauque, C. Bai, Y. Lu, J. Kenny, M. Oukka, T. B. Strom, and T. L. Rothstein. 2007. Reciprocal generation of Th1/Th17 and T (reg) cells by B1 and B2 B cells. Eur. J. Immunol. 37: 2400-2404. (Pubitemid 47423610)
35. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40. (Pubitemid 28194695)
36. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92. (Pubitemid 29096240)
37. Garrod, K. R., and M. D. Cahalan. 2008. Murine skin transplantation. J. Vis. Exp. pii: 634.
38. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17: 211-220. (Pubitemid 35245963)
39. Fehervari, Z., and S. Sakaguchi. 2004. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int. Immunol. 16: 1769-1780. (Pubitemid 40003865)
40. Fiorina, P., M. Jurewicz, K. Tanaka, N. Behazin, A. Augello, A. Vergani, U. H. von Andrian, N. R. Smith, M. H. Sayegh, and R. Abdi. 2007. Characterization of donor dendritic cells and enhancement of dendritic cell efflux with CC-chemokine ligand 21: a novel strategy to prolong islet allograft survival. Diabetes 56: 912-920. (Pubitemid 46525057)
41. Villablanca, E. J., D. Zhou, B. Valentinis, A. Negro, L. Raccosta, L. Mauri, A. Prinetti, S. Sonnino, C. Bordignon, C. Traversari, and V. Russo. 2008. Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo. J. Leukoc. Biol. 84: 871-879.
42. Lindquist, R. L., G. Shakhar, D. Dudziak, H. Wardemann, T. Eisenreich, M. L. Dustin, and M. C. Nussenzweig. 2004. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5: 1243-1250. (Pubitemid 41057739)
43. Otero, C., M. Groettrup, and D. F. Legler. 2006. Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation. J. Immunol. 177: 2314-2323. (Pubitemid 44200991)
44. Subramaniyam, D., H. Zhou, M. Liang, T. Welte, R. Mahadeva, and S. Janciauskiene. 2010. Cholesterol rich lipid raft microdomains are gateway for acute phase protein, SERPINA1. Int. J. Biochem. Cell Biol. 42: 1562-1570.
45. Bergin, D. A., E. P. Reeves, P. Meleady, M. Henry, O. J. McElvaney, T. P. Carroll, C. Condron, S. H. Chotirmall, M. Clynes, S. J. O'Neill, and N. G. McElvaney. 2010. α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J. Clin. Invest. 120: 4236-4250.
46. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1: 31-39.
47. Zhang, B., Y. Lu, M. Campbell-Thompson, T. Spencer, C. Wasserfall, M. Atkinson, and S. Song. 2007. Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes 56: 1316-1323.
48. Petrache, I., I. Fijalkowska, T. R. Medler, J. Skirball, P. Cruz, L. Zhen, H. I. Petrache, T. R. Flotte, and R. M. Tuder. 2006. alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am. J. Pathol. 169: 1155-1166. (Pubitemid 351194353)
49. Hackstein, H., and A. W. Thomson. 2004. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4: 24-34. (Pubitemid 38084129)
50. Churg, A., J. Dai, K. Zay, A. Karsan, R. Hendricks, C. Yee, R. Martin, R. MacKenzie, C. Xie, L. Zhang, et al. 2001. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab. Invest. 81: 1119-1131. (Pubitemid 32772072)
51. O'Sullivan, B. J., H. E. Thomas, S. Pai, P. Santamaria, Y. Iwakura, R. J. Steptoe, T. W. Kay, and R. Thomas. 2006. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J. Immunol. 176: 7278-7287. (Pubitemid 43849028)
52. Tilg, H., E. Vannier, G. Vachino, C. A. Dinarello, and J. W. Mier. 1993. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J. Exp. Med. 178: 1629-1636. (Pubitemid 23318441)
53. Lewis, E. C., L. Shapiro, O. J. Bowers, and C. A. Dinarello. 2005. Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc. Natl. Acad. Sci. USA 102: 12153-12158. (Pubitemid 41291144)
54. Pott, G. B., E. D. Chan, C. A. Dinarello, and L. Shapiro. 2009. Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J. Leukoc. Biol. 85: 886-895.
55. Münch, J., L. Ständker, K. Adermann, A. Schulz, M. Schindler, R. Chinnadurai, S. Pöhlmann, C. Chaipan, T. Biet, T. Peters, et al. 2007. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell 129: 263-275. (Pubitemid 46574967)
56. Brantly, M. 2002. Alpha1-antitrypsin: not just an antiprotease: extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol. Am. J. Respir. Cell Mol. Biol. 27: 652-654. (Pubitemid 35381172)
57. Petrache, I., J. Hajjar, and M. Campos. 2009. Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency. Biologics 3: 193-204.